BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS

Clinical trial NCT02351635 · COMPLETED

Trial details

NCT number: NCT02351635
Sponsor: Bühlmann Laboratories AG
Status: COMPLETED
Study type: OBSERVATIONAL

Inflammatory Bowel Disease Irritable Bowel Syndrome

Start date: 2015-01-01
Primary completion: 2018-03-01
Enrollment: 478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.